论文信息 - Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. - 字舞流文

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

G. Rimmelzwaan | R. Fouchier | J. Kreijtz | G. Sutter | A. Osterhaus | D. A. van de Vijver | E. V. van Gorp | A. Volz | Fleur M. Moesker | M. Goeijenbier | M. H. Lehmann | H. L. De Gruyter | F. Moesker | Lennert W. J. van den Dries | G. D. Mutsert | Simone Goeijenbier